{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:38:11Z","timestamp":1771508291416,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001219","name":"Lymphoma Research Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtn.2024.102202","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T16:37:43Z","timestamp":1714149463000},"page":"102202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-8452","authenticated-orcid":false,"given":"Manoj Kumar","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiren","family":"Karathia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vera Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Vicente","family":"Forero-Forero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eider","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Velez","family":"Lujan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Ivan","family":"Amaya-Chanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton Medeiros","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela M.","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A.","family":"Lengerke-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Achinko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Mari\u00f1o-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Mount","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Hannenhalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Januario E.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102202_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2040620711404469","article-title":"Treatment options for high-risk chronic lymphocytic leukaemia","volume":"2","author":"Hewamana","year":"2011","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.omtn.2024.102202_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/asheducation-2010.1.481","article-title":"Understanding and managing ultra high-risk chronic lymphocytic leukemia","volume":"2010","author":"Stilgenbauer","year":"2010","journal-title":"Hematology. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.omtn.2024.102202_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15134","article-title":"Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment","volume":"8","author":"Wong","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102202_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2013.06.052","article-title":"Orchestrated intron retention regulates normal granulocyte differentiation","volume":"154","author":"Wong","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102202_bib5","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1073\/pnas.1311839110","article-title":"Differential splicing across immune system lineages","volume":"110","author":"Ergun","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102202_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2010.07.019","article-title":"An alternative splicing network links cell-cycle control to apoptosis","volume":"142","author":"Moore","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102202_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1196\/annals.1410.001","article-title":"Stress-induced alternative splicing modulations in brain and periphery: acetylcholinesterase as a case study","volume":"1148","author":"Shaked","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.omtn.2024.102202_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1101\/gad.188037.112","article-title":"Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention","volume":"26","author":"Yap","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102202_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004105","article-title":"Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancers","volume":"11","author":"DeBoever","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.omtn.2024.102202_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajhg.2017.11.002","article-title":"The Expanding Landscape of Alternative Splicing Variation in Human Populations","volume":"102","author":"Park","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102202_bib11","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1038\/s41598-017-05537-0","article-title":"Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma","volume":"7","author":"Bjorklund","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102202_bib12","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41598-018-23226-4","article-title":"Evaluation of two main RNA-seq approaches for gene quantification in clinical RNA sequencing: polyA+ selection versus rRNA depletion","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102202_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nbt.3269","article-title":"Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation","volume":"33","author":"Gaidatzis","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102202_bib14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/srep01689","article-title":"RNA sequencing of cancer reveals novel splicing alterations","volume":"3","author":"Eswaran","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102202_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8794-7-15","article-title":"The global landscape of intron retentions in lung adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.omtn.2024.102202_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13073-015-0168-9","article-title":"Widespread intron retention diversifies most cancer transcriptomes","volume":"7","author":"Dvinge","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.omtn.2024.102202_bib17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12885-015-1708-9","article-title":"Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens","volume":"15","author":"Liao","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omtn.2024.102202_bib18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.2014.122069","article-title":"Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B","volume":"100","author":"Kashyap","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.omtn.2024.102202_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/21541264.2016.1268245","article-title":"The role of alternative splicing in cancer","volume":"8","author":"Singh","year":"2017","journal-title":"Transcription"},{"key":"10.1016\/j.omtn.2024.102202_bib20","doi-asserted-by":"crossref","first-page":"e1476","DOI":"10.1002\/wrna.1476","article-title":"Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics","volume":"9","author":"Urbanski","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.omtn.2024.102202_bib21","doi-asserted-by":"crossref","first-page":"69916","DOI":"10.18632\/oncotarget.19455","article-title":"SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2024.102202_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/leu.2014.318","article-title":"The impact of SF3B1 mutations in CLL on the DNA-damage response","volume":"29","author":"Te Raa","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.omtn.2024.102202_bib23","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1021\/jacs.5b13427","article-title":"A Carbohydrate-Derived Splice Modulator","volume":"138","author":"Dhar","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2024.102202_bib24","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/acschembio.6b00399","article-title":"Selectivity in Small Molecule Splicing Modulation","volume":"11","author":"Kumar","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2024.102202_bib25","article-title":"Anti-cancer Polyketide Compounds","volume":"1","author":"Burkart","year":"2017","journal-title":"US Patent"},{"key":"10.1016\/j.omtn.2024.102202_bib26","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1101\/gad.291872.116","article-title":"SF3B1\/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing","volume":"30","author":"Tang","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102202_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1101\/gr.152132.112","article-title":"Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia","volume":"24","author":"Ferreira","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2024.102202_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac136","article-title":"A quality control portal for sequencing data deposited at the European genome-phenome archive","volume":"23","author":"Fernandez-Orth","year":"2022","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.omtn.2024.102202_bib29","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2004-04-1233","article-title":"Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes","volume":"105","author":"Mayr","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102202_bib30","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1182\/blood-2004-10-3941","article-title":"Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma","volume":"105","author":"Mikaelsson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102202_bib31","first-page":"127","article-title":"Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications","volume":"16","author":"Farahi","year":"2019","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.omtn.2024.102202_bib32","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102202_bib33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncomms1998","article-title":"Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion","volume":"3","author":"Girard","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102202_bib34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/leu.2013.22","article-title":"Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia","volume":"27","author":"Schwaederle","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.omtn.2024.102202_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102202_bib36","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1182\/blood-2013-02-427641","article-title":"SF3B1 mutations in chronic lymphocytic leukemia","volume":"121","author":"Wan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102202_bib37","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","article-title":"Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia","volume":"30","author":"Wang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2024.102202_bib38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature14985","article-title":"The spliceosome is a therapeutic vulnerability in MYC-driven cancer","volume":"525","author":"Hsu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102202_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/bies.201500117","article-title":"Intron retention in mRNA: No longer nonsense: Known and putative roles of intron retention in normal and disease biology","volume":"38","author":"Wong","year":"2016","journal-title":"Bioessays"},{"key":"10.1016\/j.omtn.2024.102202_bib40","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/ng.3414","article-title":"Intron retention is a widespread mechanism of tumor-suppressor inactivation","volume":"47","author":"Jung","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102202_bib41","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1101\/gr.217984.116","article-title":"Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes","volume":"27","author":"Newman","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2024.102202_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.14348\/molcells.2014.2337","article-title":"Pressure-overload cardiac hypertrophy is associated with distinct alternative splicing due to altered expression of splicing factors","volume":"37","author":"Kim","year":"2014","journal-title":"Mol. Cells"},{"key":"10.1016\/j.omtn.2024.102202_bib43","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1101\/gr.265298.120","article-title":"Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains","volume":"30","author":"Wang","year":"2020","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2024.102202_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.celrep.2012.03.013","article-title":"Differential GC content between exons and introns establishes distinct strategies of splice-site recognition","volume":"1","author":"Amit","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2024.102202_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","article-title":"Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples","volume":"131","author":"Wagner","year":"2012","journal-title":"Theory Biosci"},{"key":"10.1016\/j.omtn.2024.102202_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13059-016-0881-8","article-title":"A survey of best practices for RNA-seq data analysis","volume":"17","author":"Conesa","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2024.102202_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omtn.2024.102202_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2024.102202_bib49","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3892\/ijo.2015.3104","article-title":"Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma","volume":"47","author":"Zhou","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omtn.2024.102202_bib50","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/gb-2014-15-1-r26","article-title":"The RNA-binding protein hnRNPLL induces a T\u00a0cell alternative splicing program delineated by differential intron retention in polyadenylated RNA","volume":"15","author":"Cho","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2024.102202_bib51","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/nar\/gkv1168","article-title":"A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis","volume":"44","author":"Pimentel","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102202_bib52","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3324\/haematol.2013.090183","article-title":"Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia","volume":"99","author":"Gattazzo","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.omtn.2024.102202_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12026-015-8688-3","article-title":"A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes","volume":"63","author":"McCarthy","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.omtn.2024.102202_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070352","article-title":"Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia","volume":"8","author":"Mittal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102202_bib55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2024.102202_bib56","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102202_bib57","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102202_bib58","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/1878-0261.12970","article-title":"SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis","volume":"15","author":"Yang","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omtn.2024.102202_bib59","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102202_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2016.08.036","article-title":"Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations","volume":"64","author":"Cretu","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2024.102202_bib61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-020-00220-5","article-title":"The biological function and clinical significance of SF3B1 mutations in cancer","volume":"8","author":"Zhou","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.omtn.2024.102202_bib62","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1038\/ncomms6429","article-title":"Quantitative profiling of peptides from RNAs classified as noncoding","volume":"5","author":"Prabakaran","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102202_bib63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102202_bib64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fgene.2020.00586","article-title":"Intron Retention as a Mode for RNA-Seq Data Analysis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtn.2024.102202_bib65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ng.3312","article-title":"The European Genome-phenome Archive of human data consented for biomedical research","volume":"47","author":"Lappalainen","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102202_bib66","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2024.102202_bib67","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2024.102202_bib68","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1101\/gr.133744.111","article-title":"Detecting differential usage of exons from RNA-seq data","volume":"22","author":"Anders","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2024.102202_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nbt.3172","article-title":"Ballgown bridges the gap between transcriptome assembly and expression analysis","volume":"33","author":"Frazee","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102202_bib70","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/bioinformatics\/bty896","article-title":"TPMCalculator: one-step software to quantify mRNA abundance of genomic features","volume":"35","author":"Vera Alvarez","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2024.102202_bib71","doi-asserted-by":"crossref","first-page":"D284","DOI":"10.1093\/nar\/gki078","article-title":"The PANTHER database of protein families, subfamilies, functions and pathways","volume":"33","author":"Mi","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102202_bib72","doi-asserted-by":"crossref","first-page":"D336","DOI":"10.1093\/nar\/gkv1194","article-title":"PANTHER version 10: expanded protein families and functions, and analysis tools","volume":"44","author":"Mi","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102202_bib73","doi-asserted-by":"crossref","first-page":"W77","DOI":"10.1093\/nar\/gkt439","article-title":"WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013","volume":"41","author":"Wang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102202_bib74","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","article-title":"The Reactome pathway Knowledgebase","volume":"44","author":"Fabregat","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102202_bib75","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2012-03-416461","article-title":"Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression","volume":"120","author":"Chuang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102202_bib76","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"Cline","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2024.102202_bib77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102202_bib78","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"284","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2024.102202_bib79","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12079-016-0322-1","article-title":"Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor","volume":"10","author":"Lumb","year":"2016","journal-title":"J.\u00a0Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2024.102202_bib80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1541-7786.MCR-12-0415-T","article-title":"LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells","volume":"11","author":"Talab","year":"2013","journal-title":"Mol. Cancer Res."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T18:48:48Z","timestamp":1717699728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2162253124000891"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102202","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"102202"}}